Iteos Therapeutics Stock Target Price and Analyst Consensus
| ITOS Stock | USD 6.67 0.03 0.45% |
The current analyst and expert consensus on Iteos Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Iteos Therapeutics target price consensus is 23.50 with 6 analyst opinions. Check out Macroaxis Advice on Iteos Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Iteos Stock please use our How to Invest in Iteos Therapeutics guide.The most common way Iteos Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Iteos Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Iteos Therapeutics. We strongly encourage you to use your own analysis of Iteos Therapeutics to validate this buy or sell advice. Iteos Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Iteos Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.1422.
Lowest Forecast 21.39 | Highest Forecast 26.09 | Target Price 23.5 |
It's important to approach Iteos Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Iteos Therapeutics Target Price Consensus
Iteos target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Iteos Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Strong Buy |
Most Iteos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Iteos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Iteos Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationIteos Therapeutics Target Price Projection
Iteos Therapeutics' current and average target prices are 6.67 and 23.50, respectively. The current price of Iteos Therapeutics is the price at which Iteos Therapeutics is currently trading. On the other hand, Iteos Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Iteos Therapeutics Market Quote on 10th of May 2025
Target Price
Analyst Consensus On Iteos Therapeutics Target Price
Iteos Therapeutics Analyst Ratings
Iteos Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Iteos Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Iteos Therapeutics' financials, market performance, and future outlook by experienced professionals. Iteos Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Iteos Therapeutics price targets
Iteos Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Iteos Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Iteos Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Iteos Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Iteos Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Iteos Therapeutics is a key component of Iteos Therapeutics valuation and have some predictive power on the future returns of a Iteos Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested over 70 shares | |
 | Momentum Invested over 300 shares | |
 | Driverless Cars Invested over 60 shares | |
 | Cash Cows Invested few shares | |
 | Power Assets Invested over 50 shares | |
 | Automobiles and Trucks Invested over 300 shares | |
 | FinTech Invested over 40 shares | |
 | Social Domain Invested few shares | |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.